Navigation Links
Varian Medical Systems Schedules Third Quarter FY2009 News Release and Conference Call
Date:6/23/2009

PALO ALTO, Calif., June 23 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for third quarter of fiscal year 2009 following the close of regular trading on Wednesday, July 29, 2009. The news release will be followed by a teleconference available to all interested parties at 2:00 p.m. PT. The news release and information on the conference call webcast will be available on the company website at: www.varian.com/investor. Details on the conference call and replay follow:

    Teleconference:  Telephone from within the U.S.:

                     -- Dial 1-800-260-8140 and enter access code 31906727
                        prior to the call at 2:00 p.m.PT/5:00 p.m. ET.
                     Telephone from outside the U.S.:
                     -- Dial 1-617-614-3672 and enter access code 31906727
                        prior to the call at 2:00 p.m. PT/5:00 p.m. ET.
                     *Note: If the number of lines allocated to the call is
                     exhausted, the webcast or replay should be utilized.

    Replay:          The teleconference will be rebroadcast until 8:00 p.m.
                     ET, Friday, July 31, 2009 and can be accessed by phone
                     or Web link as follows:
                     -- Telephone from within the U.S.: Dial 1-888-286-8010 
                        and enter access code 35168740.
                     -- Telephone from outside the U.S.: Dial 1-617-801-6888
                        and enter access code 35168740.
                     -- Internet: Click on the "Quarterly Conference Call"
                        icon on the company's investor relations website at
                        www.varian.com/investor
                     -- Web conferences will be archived on the company
                        website for a year.

For automatic "e-mail alerts" regarding Varian news and events, investors can subscribe on the company website: http://varian.investorroom.com/index.php?s=58.

For additional information contact Birgit Myles at 650-424-6637 or birgit.myles@varian.com.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 79 offices and facilities around the world. For more information, visit http://www.varian.com/.

    FOR INFORMATION CONTACT:
    Spencer Sias, (650) 424-5782
    Vice President, Corporate Communications
    and Investor Relations
    spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
2. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
3. Ovarian Cancer Breakthrough Heralds New Era of Treatment
4. Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan
5. Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
6. New Insights, Inroads Against Breast, Ovarian Cancers
7. New Fast and Precise Treatment Planning System Among Varian Medical Systems Highlights at American Brachytherapy Society 2009 Meeting
8. Dream team targets key driver for breast, ovarian, endometrial cancers
9. Varian Medical Systems Introduces the PaxScan 3030+ X-Ray Image Detector for Interventional Angiography
10. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
11. The Diagnosis Every Woman Dreads - Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... NORFOLK, Va. (Dec. 3, 2016) , ... (PRWEB) ... ... the nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, ... work in New Mexico with a patient engagement program. New Mexico has more ...
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce the effects ... water or limiting their exposure to the sun, according to a November 30 ... Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves looking our ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... prescriptive health insights for population health management, announces today a strategic relationship ... leverage CitiusTech’s cloud-hosted clinical rules engine that offers advanced Clinical Quality Measures ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  "Blood Tests replace Surgical ... ....." The Diagnostic, Monitoring and Screening Test ... diagnostics is occurring using in vitro blood testing ... with impressive backing, has announced a single blood ... moving faster than the market. New technology that ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
Breaking Medicine Technology: